Long-term prognosis of patients with arrhythmogenic right ventricular cardiomyopathy and implantable defibrillator

Ruíz-Salas, Amalio; Cabrera-Bueno, Fernando; García‐Pinilla, José Manuel; Barrera-Cordero, Alberto; Peña-Hernández, José; Fernández-Pastor, Julia; Medina-Palomo, Carmen; Alzueta-Rodríguez, Javier

doi:10.1016/j.ijcard.2014.04.123

Cited by 6 publications

(2 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…A total of 817 subjects with ARVC from 12 studies were finally included in our meta-analysis [4][5][6][7][8][9][10][11][12][13][14][15]. The characteristics of the individual studies are described in Table 1.…”

Section: Identified Studiesmentioning

confidence: 99%

Meta-analysis on risk stratification of malignant ventricular tachyarrhythmic events in arrhythmogenic right ventricular cardiomyopathy

Roh

Jang

Cho

2017

Yeungnam Univ J Med

View full text Add to dashboard Cite

Background: Arrhythmogenic right ventricular cardiomyopathy (ARVC) is a cardiomyopathy characterized by predominant right ventricular fibro-fatty replacement, right ventricular dysfunction and ventricular arrhythmias. It is a rare but important cause of sudden cardiac death in children and young adults. A meta-analysis on risk stratification of major ventricular tachyarrhythmic events indicating the need for implantable cardioverter defibrillator therapy in ARVC was performed. Methods: The pubmed database was searched from its inception to May 2015. Of the 433 citations identified, 12 were included in this meta-analysis. Data regarding major ventricular tachyarrhythmic events were retrieved in 817 subjects from the studies. For the variables, a combined odds ratio (OR) was calculated using a fixed-effects meta-analysis. Results: Extensive right ventricular dysfunction (OR, 2.44), ventricular late potential (OR, 1.66), inducible ventricular tachyarrhythmia during electrophysiology study (OR, 3.67), non-sustained ventricular tachycardia (OR, 3.78), and history of fatal event/sustained VT (OR, 5.66) identified as significant risk factors (p<0.0001). Conclusion:This meta-analysis shows that extensive right ventricular dysfunction, ventricular late potential, inducible ventricular tachyarrhythmia during electrophysiological study, non-sustained ventricular tachycardia, and history of sustained ventricular tachycardia/fibrillation are consistently reported risk factors of major ventricular tachyarrhythmic events indicating implantable cardioverter defibrillator therapy in patients with ARVC.

show abstract

Section: Identified Studiesmentioning

confidence: 99%

Meta-analysis on risk stratification of malignant ventricular tachyarrhythmic events in arrhythmogenic right ventricular cardiomyopathy

Roh

Jang

Cho

2017

Yeungnam Univ J Med

View full text Add to dashboard Cite

show abstract

“…There is general agreement that ICD therapy is indicated in patients who survived an episode of ventricular fibrillation (VF) or sustained VT because of their high incidence of arrhythmia recurrences, which do not have an impact for their survival. In contrast, there is much more uncertainty regarding which patients who have not had a previous sustained ventricular arrhythmia should have an ICD placed for primary prevention [6][7][8].…”

mentioning

confidence: 99%

Usefulness of antitachycardia pacing in arrhythmogenic right ventricular dysplasia/cardiomyopathy

Ruíz-Salas

Barrera-Cordero

Viñolas³

et al. 2015

International Journal of Cardiology

Self Cite

View full text Add to dashboard Cite

The pivotal role of compelling high-risk electrocardiographic markers in prediction of ventricular arrhythmic risk in arrhythmogenic right ventricular cardiomyopathy: A systematic review and meta-analysis

Iqbal,

Kamarullah,

Achmad

et al. 2024

Current Problems in Cardiology

View full text Add to dashboard Cite

Long-term prognosis of patients with arrhythmogenic right ventricular cardiomyopathy and implantable defibrillator

Cited by 6 publications

References 12 publications

Meta-analysis on risk stratification of malignant ventricular tachyarrhythmic events in arrhythmogenic right ventricular cardiomyopathy

Meta-analysis on risk stratification of malignant ventricular tachyarrhythmic events in arrhythmogenic right ventricular cardiomyopathy

Usefulness of antitachycardia pacing in arrhythmogenic right ventricular dysplasia/cardiomyopathy

The pivotal role of compelling high-risk electrocardiographic markers in prediction of ventricular arrhythmic risk in arrhythmogenic right ventricular cardiomyopathy: A systematic review and meta-analysis

Contact Info

Product

Resources

About